If the GI tract is slowed down, it makes that absorption a lot less predictable, which can disrupt the efficacy of birth control, Miller says
If youre using Tirzepatide instead, click here to learn more
Second, the off-label adoption pattern that the longevity reframing will inevitably accelerate is going to produce the next wave of monitoring, dosing, and selection problems, patients without obesity or diabetes do not have the diagnostic anchors (BMI, A1c, insulin resistance markers) that frame the on-label conversation, and the clinical infrastructure for managing GLP-1 therapy in metabolically healthy users is, charitably described, thin
Important Information Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality